Florida Senate - 2021 SB 1612 By Senator Rodriguez 39-01348-21 20211612__ 1 A bill to be entitled 2 An act relating to prescription drug coverage; 3 creating s. 627.42394, F.S.; requiring individual and 4 group health insurers to provide notice of 5 prescription drug formulary changes to current and 6 prospective insureds and the insureds’ treating 7 physicians; specifying the timeframe and manner in 8 which such notice must be provided; specifying 9 requirements for a notice of medical necessity 10 submitted by the treating physician; authorizing 11 insurers to provide certain means for submitting the 12 notice of medical necessity; requiring the Financial 13 Services Commission to adopt a certain form by rule by 14 a specified date; specifying a coverage requirement 15 and restrictions on coverage modification by insurers 16 receiving such notice; providing construction and 17 applicability; requiring insurers to maintain a record 18 of formulary changes; requiring insurers to annually 19 submit a specified report to the Office of Insurance 20 Regulation; requiring the office to annually compile 21 certain data, prepare a report and make the report 22 publicly accessible on its website, and submit the 23 report to the Governor and the Legislature; amending 24 s. 627.6699, F.S.; requiring small employer carriers 25 to comply with certain requirements for prescription 26 drug formulary changes; amending s. 641.31, F.S.; 27 providing an exception; requiring health maintenance 28 organizations to provide notice of prescription drug 29 formulary changes to current and prospective 30 subscribers and the subscribers’ treating physicians; 31 specifying the timeframe and manner in which such 32 notice must be provided; specifying requirements for a 33 notice of medical necessity submitted by the treating 34 physician; authorizing health maintenance 35 organizations to provide certain means for submitting 36 the notice of medical necessity; requiring the 37 commission to adopt a certain form by rule by a 38 specified date; specifying a coverage requirement and 39 restrictions on coverage modification by health 40 maintenance organizations receiving such notice; 41 providing construction and applicability; requiring 42 health maintenance organizations to maintain a record 43 of formulary changes; requiring health maintenance 44 organizations to annually submit a specified report to 45 the office; requiring the office to annually compile 46 certain data, prepare a report and make the report 47 publicly accessible on its website, and submit the 48 report to the Governor and the Legislature; providing 49 applicability; providing a declaration of important 50 state interest; providing an effective date. 51 52 Be It Enacted by the Legislature of the State of Florida: 53 54 Section 1. Section 627.42394, Florida Statutes, is created 55 to read: 56 627.42394 Health insurance policies; changes to 57 prescription drug formularies; requirements.— 58 (1) At least 60 days before the effective date of any 59 change to a prescription drug formulary during a policy year, an 60 insurer issuing individual or group health insurance policies in 61 this state shall notify: 62 (a) Current and prospective insureds of the change in the 63 formulary in a readily accessible format on the insurer’s 64 website; and 65 (b) Electronically and by first-class mail, any insured 66 currently receiving coverage for a prescription drug for which 67 the formulary change modifies coverage and the insured’s 68 treating physician. Such notification must include information 69 on the specific drugs involved and a statement that the 70 submission of a notice of medical necessity by the insured’s 71 treating physician to the insurer at least 30 days before the 72 effective date of the formulary change will result in 73 continuation of coverage at the existing level. 74 (2) The notice provided by the treating physician to the 75 insurer must include a completed one-page form in which the 76 treating physician certifies to the insurer that the 77 prescription drug for the insured is medically necessary as 78 defined under s. 627.732(2). The treating physician shall submit 79 the notice electronically or by first-class mail. The insurer 80 may provide the treating physician with access to an electronic 81 portal through which the treating physician may electronically 82 submit the notice. By January 1, 2022, the commission shall 83 adopt by rule a form for the notice. 84 (3) If the treating physician certifies to the insurer in 85 accordance with subsection (2) that the prescription drug is 86 medically necessary for the insured, the insurer: 87 (a) Must authorize coverage for the prescribed drug until 88 the end of the policy year, based solely on the treating 89 physician’s certification that the drug is medically necessary; 90 and 91 (b) May not modify the coverage related to the covered drug 92 during the policy year by: 93 1. Increasing the out-of-pocket costs for the covered drug; 94 2. Moving the covered drug to a more restrictive tier; 95 3. Denying an insured coverage of the drug for which the 96 insured has been previously approved for coverage by the 97 insurer; or 98 4. Limiting or reducing coverage of the drug in any other 99 way, including subjecting it to a new prior authorization or 100 step therapy requirement. 101 (4) Subsections (1), (2), and (3) do not: 102 (a) Prohibit the addition of prescription drugs to the list 103 of drugs covered under the policy during the policy year. 104 (b) Apply to a grandfathered health plan as defined in s. 105 627.402 or to benefits specified in s. 627.6513(1)-(14). 106 (c) Alter or amend s. 465.025, which provides conditions 107 under which a pharmacist may substitute a generically equivalent 108 drug product for a brand name drug product. 109 (d) Alter or amend s. 465.0252, which provides conditions 110 under which a pharmacist may dispense a substitute biological 111 product for the prescribed biological product. 112 (e) Apply to a Medicaid managed care plan under part IV of 113 chapter 409. 114 (5) A health insurer shall maintain a record of any change 115 in its formulary during a calendar year. By March 1 annually, a 116 health insurer shall submit to the office a report delineating 117 such changes made in the previous calendar year. The annual 118 report must include, at a minimum: 119 (a) A list of all drugs that were removed from the 120 formulary and the reasons for the removal; 121 (b) A list of all drugs that were moved to a tier resulting 122 in additional out-of-pocket costs to insureds; 123 (c) The number of insureds notified by the insurer of a 124 change in the formulary; and 125 (d) The increased cost, by dollar amount, incurred by 126 insureds because of such change in the formulary. 127 (6) By May 1 annually, the office shall: 128 (a) Compile the data in such annual reports submitted by 129 health insurers and prepare a report summarizing the data 130 submitted; 131 (b) Make the report publicly accessible on its website; and 132 (c) Submit the report to the Governor, the President of the 133 Senate, and the Speaker of the House of Representatives. 134 Section 2. Paragraph (e) of subsection (5) of section 135 627.6699, Florida Statutes, is amended to read: 136 627.6699 Employee Health Care Access Act.— 137 (5) AVAILABILITY OF COVERAGE.— 138 (e) All health benefit plans issued under this section must 139 comply with the following conditions: 140 1. For employers who have fewer than two employees, a late 141 enrollee may be excluded from coverage for no longer than 24 142 months if he or she was not covered by creditable coverage 143 continually to a date not more than 63 days before the effective 144 date of his or her new coverage. 145 2. Any requirement used by a small employer carrier in 146 determining whether to provide coverage to a small employer 147 group, including requirements for minimum participation of 148 eligible employees and minimum employer contributions, must be 149 applied uniformly among all small employer groups having the 150 same number of eligible employees applying for coverage or 151 receiving coverage from the small employer carrier, except that 152 a small employer carrier that participates in, administers, or 153 issues health benefits pursuant to s. 381.0406 which do not 154 include a preexisting condition exclusion may require as a 155 condition of offering such benefits that the employer has had no 156 health insurance coverage for its employees for a period of at 157 least 6 months. A small employer carrier may vary application of 158 minimum participation requirements and minimum employer 159 contribution requirements only by the size of the small employer 160 group. 161 3. In applying minimum participation requirements with 162 respect to a small employer, a small employer carrier shall not 163 consider as an eligible employee employees or dependents who 164 have qualifying existing coverage in an employer-based group 165 insurance plan or an ERISA qualified self-insurance plan in 166 determining whether the applicable percentage of participation 167 is met. However, a small employer carrier may count eligible 168 employees and dependents who have coverage under another health 169 plan that is sponsored by that employer. 170 4. A small employer carrier shall not increase any 171 requirement for minimum employee participation or any 172 requirement for minimum employer contribution applicable to a 173 small employer at any time after the small employer has been 174 accepted for coverage, unless the employer size has changed, in 175 which case the small employer carrier may apply the requirements 176 that are applicable to the new group size. 177 5. If a small employer carrier offers coverage to a small 178 employer, it must offer coverage to all the small employer’s 179 eligible employees and their dependents. A small employer 180 carrier may not offer coverage limited to certain persons in a 181 group or to part of a group, except with respect to late 182 enrollees. 183 6. A small employer carrier may not modify any health 184 benefit plan issued to a small employer with respect to a small 185 employer or any eligible employee or dependent through riders, 186 endorsements, or otherwise to restrict or exclude coverage for 187 certain diseases or medical conditions otherwise covered by the 188 health benefit plan. 189 7. An initial enrollment period of at least 30 days must be 190 provided. An annual 30-day open enrollment period must be 191 offered to each small employer’s eligible employees and their 192 dependents. A small employer carrier must provide special 193 enrollment periods as required by s. 627.65615. 194 8. A small employer carrier shall comply with s. 627.42394 195 for any change to a prescription drug formulary. 196 Section 3. Subsection (36) of section 641.31, Florida 197 Statutes, is amended to read: 198 641.31 Health maintenance contracts.— 199 (36) Except as provided in paragraphs (a), (b), and (c), a 200 health maintenance organization may increase the copayment for 201 any benefit, or delete, amend, or limit any of the benefits to 202 which a subscriber is entitled under the group contract only, 203 upon written notice to the contract holder at least 45 days in 204 advance of the time of coverage renewal. The health maintenance 205 organization may amend the contract with the contract holder, 206 with such amendment to be effective immediately at the time of 207 coverage renewal. The written notice to the contract holder must 208shallspecifically identify any deletions, amendments, or 209 limitations to any of the benefits provided in the group 210 contract during the current contract period which will be 211 included in the group contract upon renewal. This subsection 212 does not apply to any increases in benefits. The 45-day notice 213 requirement doesshallnot apply if benefits are amended, 214 deleted, or limited at the request of the contract holder. 215 (a) At least 60 days before the effective date of any 216 change to a prescription drug formulary during a contract year, 217 a health maintenance organization shall notify: 218 1. Current and prospective subscribers of the change in the 219 formulary in a readily accessible format on the health 220 maintenance organization’s website; and 221 2. Electronically and by first-class mail, any subscriber 222 currently receiving coverage for a prescription drug for which 223 the formulary change modifies coverage and the subscriber’s 224 treating physician. Such notification must include information 225 on the specific drugs involved and a statement that the 226 submission of a notice of medical necessity by the subscriber’s 227 treating physician to the health maintenance organization at 228 least 30 days before the effective date of the formulary change 229 will result in continuation of coverage at the existing level. 230 (b) The notice provided by the treating physician to the 231 health maintenance organization must include a completed one 232 page form in which the treating physician certifies to the 233 health maintenance organization that the prescription drug for 234 the subscriber is medically necessary as defined under s. 235 627.732(2). The treating physician shall submit the notice 236 electronically or by first-class mail. The health maintenance 237 organization may provide the treating physician with access to 238 an electronic portal through which the treating physician may 239 electronically submit the notice. By January 1, 2022, the 240 commission shall adopt by rule a form for the notice. 241 (c) If the treating physician certifies to the health 242 maintenance organization in accordance with paragraph (b) that 243 the prescription drug is medically necessary for the subscriber, 244 the health maintenance organization: 245 1. Must authorize coverage for the prescribed drug until 246 the end of the contract year, based solely on the treating 247 physician’s certification that the drug is medically necessary; 248 and 249 2. May not modify the coverage related to the covered drug 250 during the contract year by: 251 a. Increasing the out-of-pocket costs for the covered drug; 252 b. Moving the covered drug to a more restrictive tier; 253 c. Denying a subscriber coverage of the drug for which the 254 subscriber has been previously approved for coverage by the 255 health maintenance organization; or 256 d. Limiting or reducing coverage of the drug in any other 257 way, including subjecting it to a new prior authorization or 258 step therapy requirement. 259 (d) Paragraphs (a), (b), and (c) do not: 260 1. Prohibit the addition of prescription drugs to the list 261 of drugs covered under the contract during the contract year. 262 2. Apply to a grandfathered health plan as defined in s. 263 627.402 or to benefits specified in s. 627.6513(1)-(14). 264 3. Alter or amend s. 465.025, which provides conditions 265 under which a pharmacist may substitute a generically equivalent 266 drug product for a brand name drug product. 267 4. Alter or amend s. 465.0252, which provides conditions 268 under which a pharmacist may dispense a substitute biological 269 product for the prescribed biological product. 270 5. Apply to a Medicaid managed care plan under part IV of 271 chapter 409. 272 (e) A health maintenance organization shall maintain a 273 record of any change in its formulary during a calendar year. By 274 March 1 annually, a health maintenance organization shall submit 275 to the office a report delineating such changes made in the 276 previous calendar year. The annual report must include, at a 277 minimum: 278 1. A list of all drugs that were removed from the formulary 279 and the reasons for the removal; 280 2. A list of all drugs that were moved to a tier resulting 281 in additional out-of-pocket costs to subscribers; 282 3. The number of subscribers notified by the health 283 maintenance organization of a change in the formulary; and 284 4. The increased cost, by dollar amount, incurred by 285 subscribers because of such change in the formulary. 286 (f) By May 1 annually, the office shall: 287 1. Compile the data in such annual reports submitted by 288 health maintenance organizations and prepare a report 289 summarizing the data submitted; 290 2. Make the report publicly accessible on its website; and 291 3. Submit the report to the Governor, the President of the 292 Senate, and the Speaker of the House of Representatives. 293 Section 4. This act applies to health insurance policies, 294 health benefit plans, and health maintenance contracts entered 295 into or renewed on or after January 1, 2022. 296 Section 5. The Legislature finds that this act fulfills an 297 important state interest. 298 Section 6. This act shall take effect January 1, 2022.